Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies

Immunoproliferative Disorders trial results

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Fuxing Hospital affiliated to Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Anzhen Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Dana Farber Cancer institution Boston, Massachusetts, United States
  • Mayo Clinic Rochester Rochester, Minnesota, United States
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
  • University of Florida Division of Sponsored Programs Gainesville, Florida, United States
  • University of Kentucky, Markey Cancer Center Clinical Research Organization Lexington, Kentucky, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View all 159 locations
Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities) Commack, New York, United States